跳至主要内容
临床试验/NCT05563051
NCT05563051进行中(未招募)不适用

Kaneka Endovascular Embolization and Protection

Kaneka Medical America LLC8 个研究点 分布在 1 个国家目标入组 164 人开始时间: 2022年12月13日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
164
试验地点
8
主要终点
Adequate Occlusion

研究概览

简要总结

Prospective, multi-center, non-randomized registry / study, up to 164 patients enrolled and followed at 180 days +/- 45 days and again at 365 days +/- 90 days post procedure

详细描述

Assess and describe real world clinical data on i-ED coils Characterize the acute and long-term performance of iED coils when used for treating for an intracranial aneurysm May be used alone or in combination with other adjunctive device(s)

Study Duration

Anticipated timeline for study:

Patient enrollment in 18 - 24 months Completion of follow-up 12 months after last patient enrolled

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Target aneurysm of 4mm - 14mm in size
  • Ruptured or unruptured
  • Suitable for embolization with coils
  • May be treated with or without assist devices

排除标准

  • Unstable neurological deficit in unruptured cases (condition worsening within last 90 days)
  • Pre-planned staged procedure of target aneurysm
  • mRS score 3 or more
  • Hunt Hess Score more than 3 for subjects with ruptured aneurysm
  • Evidence of active infection (e.g.,fever, temperature >38 degrees C and/or WBC >15,000)

结局指标

主要结局

Adequate Occlusion

时间窗: 12 months

Proportion of subjects who achieve Adequate Occlusion (Modified Raymond-Roy I or II Classification)

次要结局

  • Complete Occlusion(12 months)
  • Adverse events(12 months)
  • Packing Density(12 months)
  • Modified Rankin Score(12 months)
  • Retreatment(12 months)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (8)

Loading locations...

相似试验